Susan Snodgrass

826 total citations
19 papers, 595 citations indexed

About

Susan Snodgrass is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Susan Snodgrass has authored 19 papers receiving a total of 595 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Susan Snodgrass's work include Glioma Diagnosis and Treatment (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Brain Metastases and Treatment (4 papers). Susan Snodgrass is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Histone Deacetylase Inhibitors Research (5 papers) and Brain Metastases and Treatment (4 papers). Susan Snodgrass collaborates with scholars based in United States and Switzerland. Susan Snodgrass's co-authors include C. Ajmone-Marsan, Joseph R. Berger, Carol K. Petito, Ashok Verma, William J. Harrington, William Sheremata, Steven K. H. Foung, Lynn G. Feun, Howard J. Landy and Lisa Cabral and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Neurology.

In The Last Decade

Susan Snodgrass

19 papers receiving 577 citations

Peers

Susan Snodgrass
Katsuhiko Ogawa Japan
Mickaël Bonnan France
W. A. Sheremata United States
Eduard Linetsky Israel
B. G. Weinshenker United States
Pierre Meyer France
Ruifeng Liu China
Luisa Vuolo Italy
Bill Ollier United Kingdom
Thomas L. Willmon United States
Katsuhiko Ogawa Japan
Susan Snodgrass
Citations per year, relative to Susan Snodgrass Susan Snodgrass (= 1×) peers Katsuhiko Ogawa

Countries citing papers authored by Susan Snodgrass

Since Specialization
Citations

This map shows the geographic impact of Susan Snodgrass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Snodgrass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Snodgrass more than expected).

Fields of papers citing papers by Susan Snodgrass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Snodgrass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Snodgrass. The network helps show where Susan Snodgrass may publish in the future.

Co-authorship network of co-authors of Susan Snodgrass

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Snodgrass. A scholar is included among the top collaborators of Susan Snodgrass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Snodgrass. Susan Snodgrass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Slosberg, Eric D., Susan Snodgrass, Claudia Lebedinsky, et al.. (2015). The Signature Program: Bringing the Protocol to the Patient. Clinical Pharmacology & Therapeutics. 98(2). 124–126. 23 indexed citations
3.
Lee, Eudocia Q., David A. Reardon, David Schiff, et al.. (2013). Interim analysis of a phase I/II study of panobinostat in combination with bevacizumab for recurrent glioblastoma.. Journal of Clinical Oncology. 31(15_suppl). 2013–2013. 21 indexed citations
4.
Armstrong, Edward P., Grant H. Skrepnek, Medha Sasané, Susan Snodgrass, & Samir K. Ballas. (2012). Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. Journal of Medical Economics. 16(1). 10–18. 9 indexed citations
5.
Drappatz, Jan, E. Q. Lee, Samantha N. Hammond, et al.. (2011). Phase I study of panobinostat in combination with bevacizumab for recurrent high-grade glioma. Journal of Neuro-Oncology. 107(1). 133–138. 62 indexed citations
6.
7.
Drappatz, Jan, Jeffrey J. Raizer, David Schiff, et al.. (2011). A phase I trial of LBH589 and bevacizumab for recurrent high-grade glioma (HGG).. Journal of Clinical Oncology. 29(15_suppl). 2050–2050. 6 indexed citations
8.
Richardson, Paul G., Melissa Alsina, Donna M. Weber, et al.. (2011). Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2). Blood. 118(21). 814–814. 16 indexed citations
9.
Alsina, Melissa, Sagar Lonial, D. Weber, et al.. (2010). PANORAMA 2: A phase II study of panobinostat (LBH589) in combination with bortezomib (BTZ) and dexamethasone (DEX) in patients with relapsed and BTZ-refractory multiple myeloma (MM).. Journal of Clinical Oncology. 28(15_suppl). TPS308–TPS308. 4 indexed citations
10.
Snodgrass, Susan, Douglas C. Miller, Jeffrey H. Wisoff, et al.. (2005). Recurrent Central Nervous System Medulloepithelioma. Journal of Pediatric Hematology/Oncology. 27(5). 264–266. 10 indexed citations
11.
Verma, Ashok, Joseph R. Berger, Susan Snodgrass, & Carol K. Petito. (1996). Motor neuron disease: A paraneoplastic process associated with anti‐Hu antibody and small‐cell lung carcinoma. Annals of Neurology. 40(1). 112–116. 72 indexed citations
12.
Remler, Bernd F., Richard J. Creger, Brenda Cooper, et al.. (1996). Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients. Journal of Neuro-Oncology. 27(3). 241–250. 3 indexed citations
13.
Harrington, William J., Parkash S. Gill, Susan Snodgrass, et al.. (1995). Clinical Spectrum of HTLV-I in South Florida. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 8(5). 466–473. 19 indexed citations
14.
Wolfson, Aaron H., Susan Snodgrass, James G. Schwade, et al.. (1994). The Role of Steroids in the Management of Metastatic Carcinoma to the Brain. American Journal of Clinical Oncology. 17(3). 234–238. 26 indexed citations
15.
Snodgrass, Susan, Howard J. Landy, Arnold M. Markoe, & Lynn G. Feun. (1994). Neurologic complications of Merkel cell carcinoma. Journal of Neuro-Oncology. 22(3). 231–234. 15 indexed citations
16.
Landy, Howard J., et al.. (1994). Retreatment of Intracranial Gliomas. Southern Medical Journal. 87(2). 211–214. 33 indexed citations
17.
Sheremata, William, William J. Harrington, Steven K. H. Foung, et al.. (1993). Association of ‘(tropical) ataxic neuropathy’ with HTLV-II. Virus Research. 29(1). 71–77. 40 indexed citations
18.
Harrington, William J., William Sheremata, Dipak K. Dube, et al.. (1993). Spastic ataxia associated with human T‐cell lymphotrophic virus type II infection. Annals of Neurology. 33(4). 411–414. 88 indexed citations
19.
Snodgrass, Susan, et al.. (1989). Clinical Significance of Periodic Lateralized Epileptiform Discharges. Journal of Clinical Neurophysiology. 6(2). 159–159. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuhiko Ogawa Breakdown of academic impact, for papers by Mickaël Bonnan Breakdown of academic impact, for papers by W. A. Sheremata Breakdown of academic impact, for papers by Eduard Linetsky Breakdown of academic impact, for papers by B. G. Weinshenker Breakdown of academic impact, for papers by Pierre Meyer Breakdown of academic impact, for papers by Ruifeng Liu Breakdown of academic impact, for papers by Luisa Vuolo Breakdown of academic impact, for papers by Bill Ollier Breakdown of academic impact, for papers by Thomas L. Willmon
Rankless by CCL
2026